Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank R Gupta

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Retinal Cases & Brief Reports|November 6, 2014
Salvaging recurrent scleral buckle exposure with autologous periosteal patch graftShashank R Gupta, Raj Anand, Shilpi Diwan, et al.
Indian Journal of Ophthalmology|January 19, 2021
Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF SurveyJay U Sheth, Michael W Stewart, Manoj Khatri, et al.
Retina (Philadelphia, Pa.)|October 5, 2011
Type 2 idiopathic macular telangiectasiaDhananjay Shukla, Shashank R Gupta, Nithya Neelakantan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Retinal Cases & Brief Reports|November 6, 2014
Salvaging recurrent scleral buckle exposure with autologous periosteal patch graftShashank R Gupta, Raj Anand, Shilpi Diwan, et al.
Indian Journal of Ophthalmology|January 19, 2021
Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF SurveyJay U Sheth, Michael W Stewart, Manoj Khatri, et al.
Retina (Philadelphia, Pa.)|October 5, 2011
Type 2 idiopathic macular telangiectasiaDhananjay Shukla, Shashank R Gupta, Nithya Neelakantan, et al.
Pageof 1